Page last updated: 2024-08-22

vidarabine and X-Linked Combined Immunodeficiency Diseases

vidarabine has been researched along with X-Linked Combined Immunodeficiency Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goi, K; Hara, T; Kamachi, Y; Kojima, S; Kumaki, S; Morio, T; Muramatsu, H; Sasahara, Y; Sugita, K; Takada, H; Tsuchiya, S; Urabe, T1
Dishaw, LJ; Dorsey, MJ; Morrow, MR; Petrovic, A; Sleasman, JW1
Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Inamoto, J; Kaneda, M; Kawamura, N; Kobayashi, I; Kobayashi, R; Ohkura, Y; Ohshima, J; Sato, T; Takezaki, SI; Yamada, M1

Other Studies

3 other study(ies) available for vidarabine and X-Linked Combined Immunodeficiency Diseases

ArticleYear
B-cell function after unrelated umbilical cord blood transplantation using a minimal-intensity conditioning regimen in patients with X-SCID.
    International journal of hematology, 2013, Volume: 98, Issue:3

    Topics: Antineoplastic Agents; B-Lymphocytes; Cord Blood Stem Cell Transplantation; Female; Graft vs Host Disease; HLA Antigens; Humans; Immunoglobulins; Infant; Male; Melphalan; Survival Rate; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; X-Linked Combined Immunodeficiency Diseases

2013
FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
    Immunologic research, 2009, Volume: 44, Issue:1-3

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Autoimmune Diseases; Bone Marrow Transplantation; Forkhead Transcription Factors; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin E; Infant; Interleukin-7 Receptor alpha Subunit; Male; Melphalan; T-Lymphocytes, Regulatory; Transplantation Conditioning; Vidarabine; X-Linked Combined Immunodeficiency Diseases

2009
Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID.
    Bone marrow transplantation, 2011, Volume: 46, Issue:12

    Topics: Acute Disease; Antineoplastic Agents; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Female; Fetal Blood; Graft vs Host Disease; Histocompatibility Testing; Humans; Infant; Lung Diseases, Fungal; Male; Pneumonia, Bacterial; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; X-Linked Combined Immunodeficiency Diseases

2011